ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Philip-Joet, F
Right arrow Articles by Juhan-Vague, I
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Philip-Joet, F
Right arrow Articles by Juhan-Vague, I
Eur Respir J 1995; 8: 1352-1356
Copyright © ERS Journals Ltd 1995


Original Articles

Fibrinolytic and inflammatory processes in pleural effusions

F Philip-Joet, MC Alessi, C Philip-Joet, M Aillaud, Barriere JR, A Arnaud, and I Juhan-Vague

This study was designed to evaluate major fibrinolytic parameters in relation to parameters of inflammation associated with different kinds of pleural effusion. Sixty patients with pleural effusion were studied. The underlying aetiology was empyema in 10 cases, tuberculosis in 9, cancer in 31, cardiac failure in 7, and undetermined in 3. Plasminogen, plasminogen activator inhibitor 1 (PAI-1) and 2 (PAI-2), tissue type plasminogen activator (t-PA), urokinase (u-PA) and D-dimers (D-D) were quantified in plasma samples and pleural effusion specimens. These data were then correlated with inflammatory or infectious parameters, i.e. fibrinogen, von Willebrand factor (vWF), erythrocyte sedimentation rate (ESR), protein concentration, and white blood cell count. D-D levels were higher in pleural fluid than in plasma. D-D levels were not correlated with either plasminogen activator or plasminogen activator inhibitor levels, suggesting the presence of other fibrinolytic pathways. PAI levels (PAI activity, PAI-1 antigenicity, PAI-2 antigenicity) and vWF levels were significantly higher in patients with tuberculosis and empyema than in patients with cancer or cardiac failure. Regression analysis between inflammatory and fibrinolytic parameters showed that pleural PAI levels were significantly correlated with pleural neutrophil count, vWF levels, and plasma fibrinogen levels. D-D levels were correlated with blood ESR. No significant difference in pleural t-PA, u-PA and D-D levels was observed between aetiologies. The highest pleural t-PA and u-PA values were noted in patients with cancer, especially lymphoma. Plasma t-PA levels were higher inpatients with pleural effusion secondary to congestive heart failure, but this difference did not reach statistical significance.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. A. Komissarov, A. P. Mazar, K. Koenig, A. K. Kurdowska, and S. Idell
Regulation of intrapleural fibrinolysis by urokinase-{alpha}-macroglobulin complexes in tetracycline-induced pleural injury in rabbits
Am J Physiol Lung Cell Mol Physiol, October 1, 2009; 297(4): L568 - L577.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
H.-J. Chen, W.-H. Hsu, C.-Y. Tu, Y.-H. Yu, K.-L. Chiu, L.-W. Hang, T.-C. Hsia, and C.-M. Shih
Sonographic septation in lymphocyte-rich exudative pleural effusions: a useful diagnostic predictor for tuberculosis.
J. Ultrasound Med., July 1, 2006; 25(7): 857 - 863.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C.-L. Chung, C.-H. Chen, J.-R. Sheu, Y.-C. Chen, and S.-C. Chang
Proinflammatory Cytokines, Transforming Growth Factor-{beta}1, and Fibrinolytic Enzymes in Loculated and Free-Flowing Pleural Exudates
Chest, August 1, 2005; 128(2): 690 - 697.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D. Iglesias, J. Alegre, C. Aleman, E. Ruiz, T. Soriano, L. I. Armadans, R. M. Segura, A. Angles, J. Monasterio, and T. Fernandez de Sevilla
Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions
Eur. Respir. J., January 1, 2005; 25(1): 104 - 109.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C.-F. Chian, W.-L. Su, L.-H. Soh, H.-C. Yan, W.-C. Perng, and C.-P. Wu
Echogenic Swirling Pattern as a Predictor of Malignant Pleural Effusions in Patients With Malignancies
Chest, July 1, 2004; 126(1): 129 - 134.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Ishikawa, H. Satoh, K. Sekizawa, C.-L. Chung, and S.-C. Chang
Effect of Repeated Thoracenteses on Fibrinolytic Activity in Malignant Pleural Effusion
Chest, May 1, 2004; 125(5): 1965 - 1966.
[Full Text] [PDF]


Home page
ChestHome page
C.-L. Chung, Y.-C. Chen, and S.-C. Chang
Effect of Repeated Thoracenteses on Fluid Characteristics, Cytokines, and Fibrinolytic Activity in Malignant Pleural Effusion
Chest, April 1, 2003; 123(4): 1188 - 1195.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C.-C. Hua, L.-C. Chang, Y.-C. Chen, and S.-C. Chang
Proinflammatory Cytokines and Fibrinolytic Enzymes in Tuberculous and Malignant Pleural Effusions
Chest, November 1, 1999; 116(5): 1292 - 1296.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
O Eickelberg, C. Sommerfeld, C Wyser, M Tamm, F Reichenberger, P. Bardin, M Soler, M Roth, and A. Perruchoud
MMP and TIMP expression pattern in pleural effusions of different origins
Am. J. Respir. Crit. Care Med., December 1, 1997; 156(6): 1987 - 1992.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
F. Mannello, G. Miragoli, G. Bianchi, and G. Gazzanelli
Immunoreactive Prostate-Specific Antigen in Pleural Effusions
Clin. Chem., May 1, 1997; 43(5): 847 - 848.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the European Respiratory Society.